CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)	3 Months Ended				9 Months Ended				53 Months Ended
	Sep. 30, 2011		Sep. 30, 2010		Sep. 30, 2011		Sep. 30, 2010		Sep. 30, 2011
Revenue
Operating expense
General & administrative	327,380	[1]	265,942	[1]	1,002,191	[1]	832,518	[1]	5,850,742	[1]
Total operating expense	504,489		501,288		1,560,994		1,419,622		9,061,379
Net operating loss	(504,489)		(501,288)		(1,560,994)		(1,419,622)		(9,061,379)
Other income
Interest income	870		236		2,171		1,283		75,575
Other income									244,479
Other expense	(200)		(285)		(471)		(753)		(3,371)
Total Other Income	670		(49)		1,700		530		316,683
Net Loss	(503,819)		(501,337)		(1,559,294)		(1,419,092)		(8,744,696)
Loss per share
Net loss per share, basic and diluted	$ (0.01)		$ (0.01)		$ (0.03)		$ (0.03)		$ (0.21)
Basic and diluted weighted average number of common shares outstanding	56,146,296		49,083,806		52,398,690		47,752,807		42,353,075
All Other
Operating expense
Research and development	127,109	[2]	235,346	[2]	458,803	[2]	587,104	[2]	3,048,687	[2]
Related Party Transactions
Operating expense
Research and development	$ 50,000				$ 100,000				$ 161,950

[1] General & administrative expense includes stock for services, stock option and warrant expenses of $105,491 and $106,534 for the quarters ending 9/30/2011 and 9/30/2010, respectively; $314,869 and $320,220 for the nine month periods ending 9/30/2011 and 9/30/2010, respectively; and for the period from inception through 9/30/2011 $2,579,063 for stock option and warrant expense and $300,000 in stock for services.

[2] Research and development expense includes stock option expenses of $17,406 and $36,176 for the quarters ending 9/30/2011 and 9/30/2010, respectively; $48,693 and $108,528 for the nine month periods ending 9/30/2011 and 9/30/2010, respectively; and $351,950 for the period from inception through 9/30/2011. Research and development expense also includes amortization expenses of $53,017 and $49,953 for the quarters ending 9/30/2011 and 9/30/2010, respectively; $157,490 and $145,962 for the nine month periods ending 9/30/2011 and 9/30/2010, respectively; and $737,243 for the period from inception through 9/30/2011.